# EDGAR Filing Document

**Accession Number:** 0002093101
**File Stem:** 9999999997-26-000345
**Filing Date:** 2026-2
**Character Count:** 1133
**Document Hash:** 391015d549a8dd8c467c7a9131f96344
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999997-26-000345.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 9999999997-26-000345

**CONFORMED SUBMISSION TYPE**: SEC STAFF ACTION

**CATEGORY**: ORDER

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260226

**ACTION DATE**: 20260226

**RECEIVED DATE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Atrium Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0002093101
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SEC STAFF ACTION

**BUSINESS ADDRESS:**
- **STREET 1:** 3020 CALLAN ROAD
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 858-401-7900

**MAIL ADDRESS:**
- **STREET 1:** 3020 CALLAN ROAD
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bryce Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20251022

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._